High Preoperative Neutrophil-Lymphocyte Ratio Predicts Poor Survival in Patients With Gastric Cancer

Gastric Cancer - Germany
doi 10.1007/s10120-010-0554-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Elevated Preoperative Platelet-To-Lymphocyte Ratio Predicts Poor Prognosis in Breast Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2014English

Neutrophil/Lymphocyte Ratio Predicts Chemotherapy Outcomes in Patients With Advanced Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Neutrophil-To-Lymphocyte Ratio Predicts Survival in European Patients With Hepatocellular Carcinoma Administered Sorafenib

Oncotarget
Oncology
2017English

Preoperative Platelet-To-Lymphocyte Ratio and Neutrophil-To-Lymphocyte Ratio as Predictors of Clinical Outcome in Patients With Gallbladder Cancer

Scientific Reports
Multidisciplinary
2019English

A High Monocyte-To-Lymphocyte Ratio Predicts Poor Prognosis in Patients With Advanced Gallbladder Cancer Receiving Chemotherapy

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Derived Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio May Be Better Biomarkers for Predicting Overall Survival of Patients With Advanced Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

High Blood Neutrophil-Lymphocyte Ratio Associated With Poor Outcomes in Miliary Tuberculosis

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Neutrophil-Lymphocyte Ratio Predicts Recurrence in Patients With Resected Stage 1 Non-Small Cell Lung Cancer

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2018English

High Neutrophil/Lymphocyte Ratio Is Associated With Poor Renal Outcomes in Japanese Patients With Chronic Kidney Disease

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy